AstraZeneca

Open: 64.87 Close: 65.02 Change: 0.15

The best way to get information about AstraZeneca Company Inc Stock: Use an AI.

How much time have you spent trying to decide whether investing in AstraZeneca? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, company, …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

AstraZeneca has signed a deal worth up to $247 million with U.S. biologics firm Absci. The company sees the technology as a good fit for its push to deploy AI.

Today's News

AstraZeneca agrees to pay Absci up to $247 million to collaborate on the design of an anti-cancer antibody. The company sees the technology as a good fit for its push to deploy AI. AstraZeneca has signed a deal worth up to $247 million with U.S. biologics firm Absci. The deal aims for a zero-shot generative AI model designed to create new and improved antibody therapeutics, the company said. AstraZeneca is calling off two late-stage trials into the potential benefits of its potassium-reduction drug Lokelma in treating a chronic condition called hyperkalemia in people with various heart and kidney diseases. The decision to discontinue the trials is not due to safety concerns, company says. AstraZeneca PLC 18,278 $65.02 $0.23 (0.35%) Today Watchers 18,279 52-Wk Low $61.73 52- Wk High $76.56 Market Cap $158.06B Volume (M) 36,812. Absci announces collaboration with astrazeneca to advance ai-driven oncology candidate. AstraZeneca - AZN - Stock Price Today - Zacks Is It Time to Buy AZN? Shares are up today. AstraZeneca is not responsible for the privacy policy of any third party websites. Use this link to help users with reading comprehension and vocabulary. Use the weekly Newsquiz to test your knowledge of the company. AstraZeneca will plant millions of trees in Kenya and monitor with AI in monitoring sustainable tree-planting with drone footage and satellite image data. The company will plant 200 million trees across six continents by 2030. AstraZeneca reported a non-GAAP earnings per share of $1.73; this was up 4% from the year-ago period. Cowen analyst Steve Scala is impressed by the companys sound combination of overall position and future prospects. AstraZeneca will collaborate with Earthbanc, Earthtree, Worldview Impact India, and the Hill Farmers Shiitake Mushroom Coop Society to implement a 30-year regenerative horticulture and agriculture project in the ecologically delicate Meghalaya region. Big Pharma companies believe AI can help experts develop and screen drugs at a faster rate.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

This document will help you to evaluate AstraZeneca without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, company, AI, Absci, collaborate, design, antibody, and the most common words in the summary are: astrazeneca, news, ai, subscribe, cancer, drug, see, . One of the sentences in the summary was: The company sees the technology as a good fit for its push to deploy AI.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #news #ai #subscribe #cancer #drug #see.